AEMD · Aethlon Medical Inc

$2.83 -0.10 (-3.41%) At close · Aug 14

Market Cap

$2.01M

711,136

Share-repurchase activity from the company's own XBRL filings — cash spent on equity repurchases (common and preferred combined, as reported) per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Remaining Authorization

1,091 shares

as of 2026-06-30

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2019-03-31	$193,866	—	—	10-K, filed 2019-07-01
2018-03-31	$278,633	—	—	10-K, filed 2019-07-01
2017-03-31	$378,518	—	—	10-K, filed 2018-06-08
2016-03-31	$0	—	—	10-K, filed 2017-06-28

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2018-06-30	$32,737	—	—	10-Q, filed 2018-08-08
2018-03-31	$80,106 Δ	—	—	10-K, filed 2019-07-01
2017-12-31	$35,366 Δ	—	—	10-Q, filed 2018-02-01
2017-09-30	$27,032 Δ	—	—	10-Q, filed 2017-11-02
2017-06-30	$136,129	—	—	10-Q, filed 2018-08-08
2017-03-31	$306,525 Δ	—	—	10-K, filed 2018-06-08
2016-12-31	$4,650 Δ	—	—	10-Q, filed 2018-02-01
2016-09-30	$67,343 Δ	—	—	10-Q, filed 2017-11-02
2016-06-30	$0	—	—	10-Q, filed 2017-08-10
2016-03-31	$0 Δ	—	—	10-K, filed 2017-06-28

Key facts CIK 882291 CUSIP 00808Y604 13F (30d) 19 filings 19 filers Visit website Investor relations